Authors:
Tubau, F
Fernandez-Roblas, R
Linares, J
Martin, R
Soriano, F
Citation: F. Tubau et al., In vitro activity of linezolid and 11 other antimicrobials against 566 clinical isolates and comparison between NCCLS microdilution and Etest methods, J ANTIMICRO, 47(5), 2001, pp. 675-680
Authors:
Esteban, J
Cabria, F
Rollan, E
Fernandez-Roblas, R
Gadea, I
Soriano, F
Citation: J. Esteban et al., Characterization of rapidly growing mycobacteria using a commercial identification system, EUR J CL M, 19(1), 2000, pp. 73-75
Authors:
Fernandez-Roblas, R
Cabria, F
Esteban, J
Lopez, JC
Gadea, I
Soriano, F
Citation: R. Fernandez-roblas et al., In vitro activity of gemifloxacin (SB-265805) compared with 14 other antimicrobials against intestinal pathogens, J ANTIMICRO, 46(6), 2000, pp. 1023-1027
Authors:
Torres, AJ
Valladares, LD
Jover, JM
Sanchez-Pernaute, A
Frias, J
Carcas, AJ
Coronel, P
Rodenas, E
Perez-Balcabao, I
Fernandez-Roblas, R
Moreno, M
Balibrea, JL
Citation: Aj. Torres et al., Cefminox versus metronidazole plus gentamicin in intra-abdominal infections: A prospective randomized controlled clinical trial, INFECTION, 28(5), 2000, pp. 318-322
Authors:
Esteban, J
Fernandez-Roblas, R
Cabria, F
Soriano, F
Citation: J. Esteban et al., Usefulness of the BACTEC MYCO/F lytic system for detection of mycobacteremia in a clinical microbiology laboratory, J MICROB M, 40(1), 2000, pp. 63-66
Authors:
Fernandez-Roblas, R
Esteban, J
Cabria, F
Lopez, JC
Jimenez, MS
Soriano, F
Citation: R. Fernandez-roblas et al., In vitro susceptibilities of rapidly growing mycobacteria to telithromycin(HMR 3647) and seven other antimicrobials, ANTIM AG CH, 44(1), 2000, pp. 181-182
Authors:
Esteban, J
Nieto, E
Calvo, R
Fernandez-Roblas, R
Valero-Guillen, PL
Soriano, F
Citation: J. Esteban et al., Microbiological characterization and clinical significance of Corynebacterium amycolatum strains, EUR J CL M, 18(7), 1999, pp. 518-521
Authors:
Fernandez-Roblas, R
Calvo, R
Esteban, J
Bryskier, A
Soriano, F
Citation: R. Fernandez-roblas et al., The bactericidal activities of HMR 3004, HMR 3647 and erythromycin againstGram-positive bacilli and development of resistance, J ANTIMICRO, 43(2), 1999, pp. 285-289
Authors:
Soriano, F
Fernandez-Roblas, R
Calvo, R
Garcia-Calvo, G
Pardeiro, M
Bryskier, A
Citation: F. Soriano et al., In-vitro antimicrobial activity of HMR 3004 (RU 64004) against erythromycin A-sensitive and -resistant Corynebacterium spp. isolated from clinical specimens, J ANTIMICRO, 42(5), 1998, pp. 647-649